Issue 40, 2020
From the journal:

RSC Advances

Correction: In silico and in vitro metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling

Thamer A. Alsubi,a   Mohamed W. Attwa,ab   Ahmed H. Bakheit,a   Hany W. Darwish,*ac   Hatem A. Abuelizza  and  Adnan A. Kadia  

* Corresponding authors

a Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P. O. Box 2457, Riyadh, Saudi Arabia
E-mail: hdarwish@ksu.edu.sa
Fax: +966 1146 76 220
Tel: +966 1146 70237

b Students’ University Hospital, Mansoura University, Mansoura 35516, Egypt

c Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini St., Cairo 11562, Egypt

Abstract

Correction for ‘In silico and in vitro metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling’ by Thamer A. Alsubi et al., RSC Adv., 2020, 10, 22668–22683, DOI: 10.1039/D0RA01624A.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D0RA90070B
Article type
Correction
Submitted
17 Jun 2020
Accepted
17 Jun 2020
First published
23 Jun 2020
This article is Open Access
Creative Commons BY license

RSC Adv., 2020,10, 23930-23930

Permissions

Request permissions

Correction: In silico and in vitro metabolism of ribociclib: a mass spectrometric approach to bioactivation pathway elucidation and metabolite profiling

T. A. Alsubi, M. W. Attwa, A. H. Bakheit, H. W. Darwish, H. A. Abuelizz and A. A. Kadi, RSC Adv., 2020, 10, 23930 DOI: 10.1039/D0RA90070B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements